English
4-Aminopyridine CAS 504-24-5 Assay ≥99.5% (HPLC) Factory Featured Image
  • 4-Aminopyridine CAS 504-24-5 Assay ≥99.5% (HPLC) Factory

4-Aminopyridine CAS 504-24-5 Assay ≥99.5% (HPLC) Factory

Kufotokozera Kwachidule:

Dzina la mankhwala: 4-Aminopyridine

CAS: 504-24-5

Kuyesa: ≥99.5% (HPLC)

Maonekedwe: Ufa Wakristalo Woyera Kapena Wachikasu Wapang'ono

Ubwino Wapamwamba, Kupanga Zamalonda

E-Mail: alvin@ruifuchem.com


Tsatanetsatane wa Zamalonda

Zogwirizana nazo

Zolemba Zamalonda

Kufotokozera:

Wopanga Zinthu, Kuyera Kwambiri, Kupanga Zamalonda
Dzina la mankhwala: 4-Aminopyridine
CAS: 504-24-5

Chemical Properties:

Dzina la Chemical 4-Aminopyridine
Mawu ofanana ndi mawu 4-AP;4-Pyridinamine;Fampridine;Dalfampridine;p-aminopyridine;γ-Aminopyridine
Nambala ya CAS 504-24-5
Nambala ya CAT RF-PI539
Stock Status Mu Stock, Kupanga Kukula Mpaka Matani
Molecular Formula C5H6N2
Kulemera kwa Maselo 94.12
Kusungunuka Zosungunuka m'madzi, Ethanol
Mtundu Ruifu Chemical

Zofotokozera:

Kanthu Zofotokozera
Maonekedwe Ufa Woyera Kapena Wachikasu Wamakristalo
Njira Yoyesera / Kusanthula ≥99.5% (HPLC)
Melting Point 157.0 ~ 162.0 ℃
Madzi (KF) ≤0.50%
Phulusa la Sulfate ≤0.20%
2 - Aminopyridine ≤0.10%
3 - Aminopyridine ≤0.10%
Zonse Zonyansa ≤0.50%
Test Standard Enterprise Standard
Kugwiritsa ntchito Pharmaceutical Intermediates;API

Phukusi & Kusunga:

Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi zofunika kasitomala.

Mkhalidwe Wosungira:Sungani m'mitsuko yosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi.

Ubwino:

1

FAQ:

Ntchito:

4-Aminopyridine (CAS: 504-24-5) ndi imodzi mwa atatu a isomeric amines a pyridine, ndi yoyera kwambiri, yopangidwa ndi biologically yogwira ntchito, yomwe imagwiritsidwa ntchito kwambiri mu organic synthesis, synthesis of pharmaceutical intermediates ndi Active Pharmaceutical Ingredient (API). ) kaphatikizidwe.4-Aminopyridine (4-AP, Fampridine, Dalfampridine) imagwiritsidwa ntchito ngati chida chofufuzira pozindikiritsa subtypes za njira ya potaziyamu.Amagwiritsidwanso ntchito ngati mankhwala, kuti athetse zizindikiro zina za multiple sclerosis, ndipo amasonyezedwa kuti azitha kuyenda bwino mwa anthu akuluakulu omwe ali ndi mitundu yosiyanasiyana ya matendawa.Bungwe la US Food and Drug Administration (FDA) linavomereza chigawochi pa January 22, 2010. Fampridine imagulitsidwanso ku United States ndi Acorda Therapeutics komanso ngati Fampyra ku European Union, Canada, ndi Australia.

Lembani uthenga wanu apa ndikutumiza kwa ife